Educational Teleconference: Update on Immunotherapy of Melanoma - Audio Replay

The teleconference focused on the latest information on immunotherapies of melanoma. The conference was intended for patients with melanoma or friends or family member providing information needed to understand melanoma from diagnosis, to treatment, to long term follow up.

Speaker: Jedd Wolchok, M.D., Ph.D.
Moderator: Lynn Schuchter, M.D.

Dr. Jedd Wolchok, is an Assistant Attending Physician at Memorial Sloan-Kettering Cancer Center. Dr. Wolchok is a member of the faculty of Memorial Sloan-Kettering Cancer Center with expertise in the treatment of metastatic melanoma. His specific research interest is novel immunologic therapies and he has been involved in the development of the DNA vaccine program at every level, from pre-clinical studies in mouse models through clinical trials. He has authored numerous articles concerning DNA vaccines and clinical care of melanoma, and he co-authored two chapters in the definite textbook, Cutaneous Melanoma. Dr. Wolchok received his advanced education at New York University where he earned an M.D. as well as a Ph.D. in microbiology.

Dr. Lynn Schuchter is a Professor of Medicine. She is the Director of the Melanoma Program at the Abramson Cancer Center of the University of Pennsylvania as well as the Director of the Clinical Research Unit at the Cancer Center. Dr. Schuchter’s research focuses on a new approach to cancer treatment for patients with melanoma known as molecularly targeted therapy. Dr. Schuchter is also involved with numerous cancer vaccine trials. She is the Co-Principal Investigator of the Skin Cancer SPORE grant at the University of Pennsylvania/Wistar Institute. Dr. Schuchter completed her oncology fellowship at the John’s Hopkins Cancer Center. She joined the faculty of the University of Pennsylvania in 1989. Dr. Schuchter is on the Melanoma Research Foundation Board and is the Chair of the Scientific Advisory Board for the MRF.